<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&ev=PageView&noscript=1">
Blog

Compliance In Focus

remote services

LEARN MORE ABOUT REMOTE SERVICES

Keep Your Clinical Trial Moving from a Distance

You want to keep your trial on track, but physical distancing and travel restrictions have made it difficult. Fortunately, IMARC has experience providing remote services.

FILTER BY:

Newest Post

Posted by Emily Haglund on Tue, Oct 25, 2016

Increased Transparency Requirements with clinicaltrials.gov

The US Department of Health and Human Services (DHHS) recently released a final rule regarding the specific requirements for the registering and results submission of clinical trials within the clinicaltrials.gov database. As previously, the final rule applies to “responsible parties” for “applicable clinical trials.” Responsible parties are frequently the sponsor of a clinical trial or principal investigator. Applicable clinical trials must meet certain criteria.

Topics: National Institutes of Health, FDA ClinicalTrials.gov, The Department of Health and Human Services

Posted by John Lehmann on Mon, Nov 06, 2017

Unapproved Devices on ClinicalTrials.gov?

Currently, trial results for are only required to be submitted to the online database for cleared or approved devices.  However, a November 19th proposal from the National Institutes of Health which would require trial results and descriptive information for devices and device indications that have yet to be cleared or approved by FDA would be posted on the public ClinicalTrials.gov website.  The proposal would give trial sponsors up to three years between the completion of the trial and when results need to be submitted to NIH if they are legitimately working towards reaching the market.

Topics: NIH, Unapproved Devices, FDA ClinicalTrials.gov